---
title: "Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Specific populations questions"
description: "Specific populations questions on Shingrix (Zoster Vaccine Recombinant, Adjuvanted) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Pregnancy and breastfeeding. Questions: Can Shingrix be given during pregnancy? Can Shingrix be given while breastfeeding? Can Shingrix be given to people younger than 18? 3 questions quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/shingrix/specific-populations"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Shingrix (Zoster Vaccine Recombinant, Adjuvanted), all indications: Specific populations questions

Manufacturer: GlaxoSmithKline Biologicals; GlaxoSmithKline  
Prescribing information: [Shingrix](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF)  
Indication pages: [Herpes zoster prevention](https://www.evicenter.com/medical-information/shingrix--herpes-zoster-prevention)

## Pregnancy and breastfeeding

<a id="shingrix-pregnancy"></a>

### Can Shingrix be given during pregnancy?

> “All pregnancies have a risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the 
> estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 
> 4% and 15% to 20%, respectively. The data are insufficient to establish if there is vaccine-associated risk with 
> SHINGRIX in pregnant women.”

Source: [SHINGRIX: Prescribing information, page 14, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=14)

> “A developmental toxicity study was performed in female rats administered SHINGRIX or the AS01B adjuvant 
> alone prior to mating, during gestation, and during lactation. The total dose was 0.2 mL on each occasion (a 
> single human dose of SHINGRIX is 0.5 mL). This study revealed no adverse effects on fetal or pre-weaning 
> development due to SHINGRIX (see Data).”

Source: [SHINGRIX: Prescribing information, page 14, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=14)

> “There is currently no recommendation for SHINGRIX use in pregnancy; therefore, providers should consider delaying SHINGRIX until after pregnancy. There is no recommendation for pregnancy testing before vaccination<sup>1</sup>”

Source: [SHINGRIX: CDC Recommendations, captured 2026-11-14](https://shingrixhcp.com/home-ic/who-to-vaccinate/cdc-recommendations/#:~:text=There%20is%20currently%20no%20recommendation,recommendation%20for%20pregnancy%20testing%20before)

Note: The last passage appears on the CDC Recommendations page of the immunocompromised section of the Shingrix HCP site, which cites the 2022 ACIP recommendations for immunocompromised adults aged 19 and older.

<a id="shingrix-breastfeeding"></a>

### Can Shingrix be given while breastfeeding?

> “It is not known whether SHINGRIX is excreted in human milk. Data are not available to assess the effects of 
> SHINGRIX on the breastfed infant or on milk production/excretion. 
> The developmental and health benefits of breastfeeding should be considered along with the mother’s clinical 
> need for SHINGRIX and any potential adverse effects on the breastfed child from SHINGRIX or from the 
> underlying maternal condition. For preventive vaccines, the underlying maternal condition is susceptibility to 
> disease prevented by the vaccine.”

Source: [SHINGRIX: Prescribing information, page 14, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=14)

## Specific populations

<a id="shingrix-under-18"></a>

### Can Shingrix be given to people younger than 18?

> “Safety and effectiveness in individuals younger than 18 years have not been established.”

Source: [SHINGRIX: Prescribing information, page 15, captured 2026-11-14](https://gskpro.com/content/dam/global/hcpportal/en_US/Prescribing_Information/Shingrix/pdf/SHINGRIX.PDF#page=15)

## Related pages
- [Medical information: Shingrix (Zoster Vaccine Recombinant, Adjuvanted): All indications](https://www.evicenter.com/medical-information/shingrix)
- [Indication](https://www.evicenter.com/medical-information/shingrix/indication)
- [Pharmacology](https://www.evicenter.com/medical-information/shingrix/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/shingrix/safety)
- [Dosing and administration](https://www.evicenter.com/medical-information/shingrix/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/shingrix/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/shingrix/access-and-coverage)
- [Guidelines](https://www.evicenter.com/medical-information/shingrix/guidelines)
